Adalimumab

Overview

4.7 out of 5 (115 Reviews)

Credits

1.50

Post Assessment Questions

6

Start Date

1 Sep 2023

Last Review Date

12 Nov 2023

Expiration Date

31 Aug 2026

Estimated Time To Finish

90 Minutes


Unlimited Nurse CE

Stay up to date on the latest medical knowledge with 6670 CE activities. In these online self-assessment activities, read our reference articles and test your knowledge with more than 7922 hours of CE.

1 Year Unlimited Nurse CE

Access to all the Unlimited Nurse CE activities in all specialties.

$39.99 per 1 year per user
 
Need Help?  If you have a system or content concerns, please contact support@statpearls.com

Activity Description

Adalimumab is a fully human, recombinant monoclonal antibody with high affinity and was the third tumor necrosis factor-alpha (TNF-α) inhibitor. Adalimumab is used to treat various autoimmune conditions such as rheumatoid arthritis, ankylosing spondylitis, psoriasis, psoriatic arthritis, Crohn disease, and ulcerative colitis. The original adalimumab molecule received its initial approval from the U.S. Food and Drug Administration (FDA) for treating rheumatoid arthritis. This activity comprehensively reviews the indications, mechanism of action, administration, potential adverse effects, and contraindications of adalimumab, providing the interprofessional healthcare team with the necessary information to effectively utilize the drug and treat certain autoimmune conditions. This topic also emphasizes the warnings, precautions, and potential drug-drug interactions associated with adalimumab when administered to patients with autoimmune disorders.


Target Audience

This activity has been designed to meet the educational needs of physicians, physician associates, nurses, pharmacists, and nurse practitioners.

Learning Objectives

At the conclusion of this activity, the learner will be better able to:

  • Identify appropriate indications for adalimumab therapy based on the patient's medical history, clinical presentation, and relevant diagnostic findings.

  • Implement a standardized dosing and monitoring protocol for patients initiating adalimumab therapy, ensuring adherence to recommended treatment regimens.

  • Assess patient response to adalimumab treatment, including evaluating changes in disease activity, symptoms, and adverse events.

  • Collaborate with multidisciplinary healthcare teams, including rheumatologists, gastroenterologists, nurses, and pharmacists, to provide comprehensive patient care, improve patient outcomes, and address complex patient needs.

Disclosures

StatPearls, LLC requires everyone who influences the content of an educational activity to disclose relevant financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant conflict(s) of interest have been mitigated. Hover over contributor names for financial disclosures. Others involved in planning this educational activity have no relevant financial relationships to disclose.

Commercial Support: This activity has received NO commercial support.

Continuing Education Accreditation Information

In support of improving patient care, StatPearls, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

 

Nurses: StatPearls designates this activity for 1.50 ANCC contact hour(s). Nurses should only claim credit commensurate with the extent of their participation in the activity.

Please consult your professional licensing board for information on the applicability and acceptance of continuing education credit for this activity.

Method of Participation and Credit

  1. Register for the activity.    
  2. Review the target audience, learning objectives, and disclosure information.
  3. Study the educational content of the enduring material.
  4. Choose the best answer to each activity test question. To receive credit and a certificate, you must pass the test questions with a minimum score of 100%.
  5. Complete the post-activity assessment survey.

If you have concerns regarding the CE/CME system, please contact support@statpearls.com.

Disclaimer

This educational activity was planned and produced in accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education. Faculty may discuss investigational products or off-label uses of products regulated by the US Food and Drug Administration. Readers should verify all information before employing any therapies described in this educational activity.

The information provided for this activity is for continuing education purposes only and is not meant to substitute for the independent medical/clinical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition. The information presented does not necessarily reflect the views of StatPearls or any commercial supporters of educational activities on statpearls.com. StatPearls expressly disclaims responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through a participant's misunderstanding of the content.

Unapproved Uses of Drugs/Devices: In accordance with FDA requirements, the audience is advised that information presented in this continuing education activity may contain references to unlabeled or unapproved uses of drugs or devices. Please refer to the FDA-approved package insert for each drug/device for full prescribing/utilization information.

Cancellation Policy: Please see the cancellation policy. StatPearls, LLC reserves the right to cancel any course due to unforeseen circumstances.

 

 
 

Reviews

Hurline S. on 10/6/2021

Raul C. on 12/6/2021

Robin Z. on 1/25/2022

Shelia C. on 5/14/2022

Deanna K. on 5/22/2022

Nathan S. on 6/19/2022

Maylin G. on 10/10/2022

Dr.NIRMALA M. on 10/30/2022

efstathia c. on 12/26/2022

Ravi J. on 12/31/2022

Stephanie F. on 2/15/2023

patricia h. on 11/11/2021

Rose F. on 2/28/2023

Kathleen D. on 10/26/2021

Alexander D. on 3/27/2023

Kristy T. on 2/15/2023

Holly J. on 12/12/2022

Nextgen l. on 12/4/2022

Amr K. on 11/30/2022

Reena R. on 8/7/2023

James A. on 11/24/2022

Theodore B. on 11/3/2022

Nicole G. on 9/24/2022

Steve R. on 8/6/2022

ROSEMARY D. on 10/7/2023

Stephen N. on 10/24/2023

Clifford A. on 8/6/2022

Shannon j. on 7/18/2022

Richard M. on 7/14/2022

Nancy F. on 6/27/2022

Ejaz J. on 6/5/2022

Aimee G. on 11/27/2023

Stephen A. on 5/31/2022

Paul H. on 5/4/2022

YOUN JU L. on 4/19/2022

Paul F. on 4/5/2022

Svetlana D. on 12/11/2023

Rachel d. on 3/3/2022

devin n. on 2/26/2022

Hope H. on 12/17/2021

Thank you.

Douglas T. on 12/5/2021

Joanne S. on 3/13/2023

Amber S. on 6/13/2023

Dr. J. on 12/31/2023

Antonio D. on 12/31/2023

jubril o. on 2/8/2023

long h. on 12/15/2022

Please submit my MOC points to the American Board of Internal Medicine ABIM for Matthew Ornstein MD

Matthew O. on 9/24/2023

Revathi K. on 1/5/2024

Kinga V. on 4/16/2023

Raymond E. on 1/9/2024

Wojciech F. on 1/10/2024

George M. on 1/18/2024

Mary Y. on 7/12/2023

Truclinh N. on 2/20/2024

Jennifer F. on 7/15/2023

Ravi J. on 9/11/2023

John T. on 9/22/2023

Lyonschvala n. on 9/24/2023

robert s. on 10/30/2023

larry N. on 11/9/2023

Angela P. on 3/18/2024

Kaman C. on 3/21/2024

Erika G. on 1/1/2024

Laura l. on 3/30/2024

Kritsen Z. on 1/2/2024

Mohammad I. on 3/31/2024

Tiffany M. on 4/5/2024

larry m. on 4/6/2024

Alexander H. on 3/1/2024

Ralf T. on 4/18/2024

Michael A. on 1/8/2024

Larry M. on 11/10/2023

no mention of anti adalimumab ab formation

William S. on 11/12/2023

Elisabeth I. on 11/23/2023

Melissa B. on 11/29/2023

Stephanie H. on 5/14/2024

kristi f. on 11/30/2023

Carolyn B. on 12/3/2023

Elizabeth F. on 5/21/2024

Drew H. on 12/5/2023

Georgina S. on 12/18/2023

Aviva Z. on 12/19/2023

scott h. on 12/21/2023

Arkam R. on 12/24/2023

Hilina y. on 6/20/2024

Selma C. on 12/25/2023

Aurelio T. on 12/27/2023

thomas r. on 7/7/2024

Durathun F. on 7/9/2024

Ikechukwu A. on 7/15/2024

Nithya P. on 3/30/2024

James R. on 3/30/2024

cyrus i. on 4/11/2024

Shari M. on 2/23/2024

Nicole T. on 2/23/2024

Steve R. on 4/29/2024

THERESA M. on 3/4/2024

Mark G. on 3/13/2024

musib g. on 5/5/2024

Christopher K. on 3/15/2024

JEANNETTE A. on 3/24/2024

John K. on 5/10/2024

Chandler P. on 5/10/2024

Eric P. on 5/11/2024

Christopher V. on 6/23/2024

ishvar p. on 5/17/2024

Patricia S. on 1/31/2024

James N. on 5/23/2024

Nicole Y. on 5/27/2024

Erica D. on 5/27/2024

Aneesh M. on 5/28/2024

James M. on 6/25/2024

Shadi S. on 7/2/2024

Lea S. on 7/23/2024

Unlimited Nurse CE

Stay up to date on the latest medical knowledge with 6670 CE activities. In these online self-assessment activities, read our reference articles and test your knowledge with more than 7922 hours of CE.

1 Year Unlimited Nurse CE

Access to all the Unlimited Nurse CE activities in all specialties.

$39.99 per 1 year per user